Category Archives: Health

Morocco Oral Care Market

Oral CareOral care increased in current value by 11% in 2016 as volume sales rose by 9% over the course of the year. However, consumers are showing greater interest in products which offer whitening features as any Moroccans are increasingly keen on having a shiny smile because of the growing advertising of the importance of having as beautiful a smile as the majority of models and presenters that appear on television.

Oral Care in Morocco report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.

Request for Sample Market Report @http://www.aarkstore.com/sample/512337

Product coverage: Dental Floss, Denture Care, Mouth Fresheners, Mouthwashes/Dental Rinses, Tooth Whiteners, Toothbrushes, Toothpaste.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Oral Care market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the markets major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Related Market Research Reports :

Global Pet Oral Care Market Size, Status and Forecast 2022

United States Personal Care Ingredients Market Report 2017

Toilet Care in Sweden

About Aarkstore:

Aarkstore Enterprise is among global marketing research companies involved in selling market reports across different industries and countries. We help serve thousands of clients annually with syndicated, custom market research and consulting. Collaborating with renowned market research partners, we have continued to etch our presence as an established as channel sales partner of market research intelligence on various frontiers. Clients from all sectors, including public, private, and commercial are endowed with best data modelling and processing structures with custom reports.

For further details, please Contact Us

Global Immunology Market Size and Revenue Forecasts

ImmunologySummary
Immune-mediated inflammatory diseases are a very common set of chronic disorders that affect 5–7% of western populations. Although they are often disparate in terms of their symptoms and key patient demographics, they are pathophysiologically linked, being characterized by dysregulation of immune pathways and an inappropriate immune response. Generally, disease-modifying anti-rheumatic drugs, a highly genericized class of systemic small-molecule-based agents, are used in the first-line treatment of these diseases. These are supplemented in many cases by shorter-term glucocorticoid therapy, another class of highly genericized systemic agents.

However, as these therapies often fail to elicit an adequate long-term response, a large second-line therapy segment has emerged in these markets, beginning with the approval of Remicade (infliximab) and Enbrel (etanercept) in 1998. This segment consists largely of premium systemic monoclonal Antibodies (mAbs), which are highly commercially successful due to their widespread usage and high cost. Although the patents for many of these mAbs either have already expired or are due to expire during the forecast period, the market is expected to experience continued growth.

Request for Sample Market Report @http://www.aarkstore.com/sample/184047

Scope
Although the patents for many of these mAbs either have already expired or are due to expire during the forecast period, the market is expected to experience continued growth, from $61.5 billion in 2015 to $74.2 billion in 2022, at a compound annual growth rate of 2.71%.
– What factors are driving the market growth?
– How can the factors limiting growth be overcome?
There is a very large pharmaceutical pipeline for immunology, consisting of 1,838 products in active development. However, the commercial performance of the products in the late-stage pipeline is expected to be moderate.
– What gaps in the market are being addressed by the most promising of these late-stage pipeline products?
– How does the composition of the pipeline compare with that of the existing market?
Several key commercially successful products, including Humira (adalimumab) and Remicade, are due to lose patent protection in the forecast period.
– How will this affect their revenues in this period?
– How are their manufacturers, AbbVie and Johnson & Johnson, responding to this?

Reasons to buy market research
This report will allow you to –
– Understand the current clinical and commercial landscape by considering disease pathogenesis, diagnosis, prognosis and the treatment options available at each stage of diagnosis
– Visualize the composition of the immunology market across each indication, in terms of dominant molecule types and targets, highlighting the key commercial assets and players
– Analyze the immunology pipeline and stratify by stage of development, molecule type and molecular target, with a granular breakdown across key indications
– Understand the growth in patient epidemiology and market revenues for the immunology market globally and across the key players and product types
– Stratify the market in terms of the split between generic and premium products and assess the role of these product types in the treatment of the various immunological disorders

Related Market Research Reports :

About Aarkstore:

Aarkstore Enterprise is among global marketing research companies involved in selling market reports across different industries and countries. We help serve thousands of clients annually with syndicated, custom market research and consulting. Collaborating with renowned market research partners, we have continued to etch our presence as an established as channel sales partner of market research intelligence on various frontiers. Clients from all sectors, including public, private, and commercial are endowed with best data modelling and processing structures with custom reports.

For further details, please Contact Us

Womens Health Cluster Drug Development Pipeline Review

Womens Health Cluster DrugSummary

This report provides an overview of the womens health pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for female infertility, polycystic ovarian syndrome and endometriosis, and also features dormant and discontinued projects.

The three key disorders covered in this report are largely driven by dysfunction of the endocrine system, but have a broad range of effects. Infertility is defined as the inability to get pregnant after a year of unprotected intercourse. Female infertility can be also be caused by a number of factors, which include damage to fallopian tubes, hormonal causes, cervical causes, uterine causes, unexplained infertility. Polycystic ovary syndrome (PCOS) is a common hormonal disorder among women of reproductive age. Symptoms include menstrual abnormality, acne, thinning hair on the scalp, weight gain, excess androgen and polycystic ovaries. Finally, endometriosis is an often painful disorder in which tissue that normally lines the inside of uterus (the endometrium) grows outside the uterus (endometrial implant). Symptoms include pelvic pain, menstrual cramps, inflammation, infertility and abnormal bleeding.

Request for Sample Market Report @http://www.aarkstore.com/sample/474233

Scope

– Which companies are the most active within the pipeline for womens health therapeutics?
– Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
– To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?

Reasons to buy market report

– Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
– Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
– Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these

Related Market Research Reports:

Global Womens Health Diagnostics Market Research Report 2016

About Aarkstore:

Aarkstore Enterprise is among global marketing research companies involved in selling market reports across different industries and countries. We help serve thousands of clients annually with syndicated, custom market research and consulting. Collaborating with renowned market research partners, we have continued to etch our presence as an established as channel sales partner of market research intelligence on various frontiers. Clients from all sectors, including public, private, and commercial are endowed with best data modelling and processing structures with custom reports.

For further details, please Contact Us

For More details Visit : Womens Health Cluster Drug Development Pipeline Review, 2017Womens Health Cluster Drug Development Pipeline Review, 2017

China Anti-Obesity Drugs Industry Assessments

Anti-Obesity DrugsChinas demand for Anti-Obesity Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines Chinas economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2006, 2011 and 2016) and long-term forecasts through 2021 and 2026 are presented. Major producers in China are profiled.

Request for Sample Market Report @ http://www.aarkstore.com/sample/71460

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

Related Market Research Reports:

Anti-Obesity Drugs Industry Forecasts – China Focus

United States Anti-Obesity Drugs Market Report 2017

Europe Anti-Obesity Drug Market Report 2016

About Aarkstore:

Aarkstore Enterprise is among global marketing research companies involved in selling market reports across different industries and countries. We help serve thousands of clients annually with syndicated, custom market research and consulting. Collaborating with renowned market research partners, we have continued to etch our presence as an established as channel sales partner of market research intelligence on various frontiers. Clients from all sectors, including public, private, and commercial are endowed with best data modelling and processing structures with custom reports.

For further details, please Contact Us

Sinusitis – Pipeline Review, H1 2017

SinusitisSummary

Sinusitis is characterized by inflammation of the sinuses. This inflammation usually stems from infection caused by a viral or bacterial infection or by an allergy Symptoms include congestion and obstruction in the nose, pain, tenderness, hyposmia, halitosis, cough, toothache, headache and pain over the cheeks just below the eyes. Risk factors include asthma, nasal passage abnormality, immune system disorder, such as HIV/AIDS or cystic fibrosis and another allergic condition.

Request for Sample Market Report @http://www.aarkstore.com/sample/441798

Report Highlights

Global Markets Directs Pharmaceutical and Healthcare latest pipeline guide Sinusitis – Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Sinusitis (Ear Nose Throat Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Sinusitis (Ear Nose Throat Disorders) pipeline guide also reviews of key players involved in therapeutic development for Sinusitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 4, 4, 3, 5 and 2 respectively.

Scope

– The pipeline guide provides a snapshot of the global therapeutic landscape of Sinusitis (Ear Nose Throat Disorders).
– The pipeline guide reviews pipeline therapeutics for Sinusitis (Ear Nose Throat Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Sinusitis (Ear Nose Throat Disorders) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Sinusitis (Ear Nose Throat Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

Reasons to buy market report

– Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
– Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
– Find and recognize significant and varied types of therapeutics under development for Sinusitis (Ear Nose Throat Disorders).
– Classify potential new clients or partners in the target demographic.
– Develop tactical initiatives by understanding the focus areas of leading companies.
– Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
– Formulate corrective measures for pipeline projects by understanding Sinusitis (Ear Nose Throat Disorders) pipeline depth and focus of Indication therapeutics.

Related Market Research Reports:

Neuromyelitis Optica (Devic’s Syndrome) – Pipeline Review, H1 2017

Friedreich Ataxia – Pipeline Review, H1 2017

Alcoholic Hepatitis – Pipeline Review, H1 2017

About Aarkstore:

Aarkstore Enterprise is among global marketing research companies involved in selling market reports across different industries and countries. We help serve thousands of clients annually with syndicated, custom market research and consulting. Collaborating with renowned market research partners, we have continued to etch our presence as an established as channel sales partner of market research intelligence on various frontiers. Clients from all sectors, including public, private, and commercial are endowed with best data modelling and processing structures with custom reports.

For further details, please Contact Us

Insulin Pen Market is likely to reach more than US$ 12 Billion by the year end of 2022.

Insulin PenMarket growth can be attributed to factors such as growing diabetes patient population, high adoption rate, user–friendly design, rising popularity among consumers, help avoid over/under–dosing of insulin, rising market demand for human insulin analogs, government support and technological advancements in the field of insulin pen devices

Insulin Pen Users Insights

China is the leading consumers of insulin pen where XX% of the diabetic population prefer insulin pen. India and Germany have shown its potential to become 2nd and 3rd popular insulin pen users. United States is the fourth leading consumers of insulin pen. Japan and Brazil hold the fifth and sixth leading consumers of insulin pen.

In terms of reusable insulin pen users, China gained its top position as the biggest overall consumer of reusable insulin pen. India and Germany grabbed the #2 and #3 position with XX% and XX% share in 2016 and is likely to maintain its position till the forecast period.

Request for Sample Market Report @ http://www.aarkstore.com/sample/445912

Insulin Pen Market Insights

United States is expected to lead the insulin pen market with a total market share of over 20% by 2022. China and Japan held the #2 and #3 largest market share and is expected to maintain its dominant position during the forecast period.

In terms of Reusable Insulin Pen Market, China and Germany will lead the reusable insulin pen market with more than combined 75% market share by 2022.

In terms of Prefilled Insulin Pen Market, United States accounted for the largest share of the insulin pen market in 2016, followed by Japan and Germany. United States is expected to register the highest CAGR during the forecast period.

Ten Major Markets(10MM) Covered in the Report are as follows

1. United States
2. United Kingdom
3. France
4. Italy
5. Spain
6. Germany
7. Japan
8. China
9. India
10. Brazil

Key Companies Covered in the Report are as follows

1. Novo Nordisk
2. Eli Lilly
3. Sanofi
4. Owen Mumford
5. Ypsomed

Related Market Research Reports:

China Touch Pen Market Research Report 2017

Global Insulin Glargine Market Professional Survey Report 2017

About Aarkstore:

Aarkstore Enterprise is among global marketing research companies involved in selling market reports across different industries and countries. We help serve thousands of clients annually with syndicated, custom market research and consulting. Collaborating with renowned market research partners, we have continued to etch our presence as an established as channel sales partner of market research intelligence on various frontiers. Clients from all sectors, including public, private, and commercial are endowed with best data modelling and processing structures with custom reports.

For further details, please Contact Us

Seasonal Influenza Vaccine Market in Nordic Countries

Nordics Seasonal Influenza VaccineNordics Seasonal Influenza Vaccine Market in (Denmark, Finland, Iceland, Norway & Sweden) By (Child & Adult) Vaccination Forecast report published by Renub Research. According to this report, Sweden is having the highest seasonal influenza vaccine market share. In terms of children vaccination, Sweden & Denmark hold nearly 70 percent market share in 2016 whereas, in adult vaccination segments, these two will share more than 60 percent market share by 2022.

Request for Sample Market Report @ http://www.aarkstore.com/sample/436146

This report provides a complete analysis of 5 Nordic countries (Denmark, Finland, Iceland, Norway and Sweden) Seasonal Influenza Vaccine Market for Childhood & Adolescent, Number of Vaccinated Population for Childhood & Adolescent and Forecast till 2022. All the 5 countries in the report have been studied from 2 viewpoints.

1. Seasonal Influenza Vaccine Market in Nordic Countries (2011 – 2022)

• Seasonal Influenza Vaccine Market & Forecast

• Children Seasonal Influenza Vaccine Market & Forecast

• Adult Seasonal Influenza Vaccine Market & Forecast

2. Seasonal Influenza Vaccinated Population in Nordic Countries (2011 – 2022)

• Seasonal Influenza Vaccinated Population & Forecast

• Children Seasonal Influenza Vaccinated Population & Forecast

• Adult Seasonal Influenza Vaccinated Population & Forecast

Countries studied in the report are as follows

1. Denmark

2. Finland

3. Iceland

4. Norway

5. Swede

Related Market Research Reports:

Seasonal Influenza Vaccination Market in Lithuania, Estonia, Latvia (Baltic Countries) By (Child & Adult) Forecast

EpiCast Report: Seasonal Influenza – Epidemiology Forecast to 2025

Seasonal Influenza Therapeutics in Asia-Pacific Markets to 2022 – Growth Driven by Rising Elderly Population, Growing Awareness and Launch of Quadrivalent Therapies

About Aarkstore:

Aarkstore Enterprise is among global marketing research companies involved in selling market reports across different industries and countries. We help serve thousands of clients annually with syndicated, custom market research and consulting. Collaborating with renowned market research partners, we have continued to etch our presence as an established as channel sales partner of market research intelligence on various frontiers. Clients from all sectors, including public, private, and commercial are endowed with best data modelling and processing structures with custom reports.

For further details, please Contact Us

%d bloggers like this: